11 – 20 of 106
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
(
- Contribution to journal › Article
-
Mark
Targeting the stressed tumor niche of glioblastoma: Tumor microenvironment and surface antigens
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Effectiveness and infectious complications of BCMA T-cell engagers in treating multiple myeloma : Real-world evidence from Sweden
(
- Contribution to journal › Article
-
Mark
IL-2-mediated hepatotoxicity : knowledge gap identification based on the irAOP concept
(
- Contribution to journal › Article
-
Mark
Revival of recombinant IL-2 therapy–approaches from the past until today
(
- Contribution to journal › Scientific review
-
Mark
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217
(
- Contribution to journal › Article
-
Mark
Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Defining neuroblastoma : From origin to precision medicine
(
- Contribution to journal › Scientific review
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
(
- Contribution to journal › Article
- 2023
-
Mark
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma : 2023 Update
(
- Contribution to journal › Scientific review